Assignee
ENGENE INC
CA·11 granted patents·9 pending applications·19 citations·filing 2001–2024
Top patents by PatentIndex Score
20 records- 0188US2025127925A1Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivoENGENE INC·Filed 2024·Application pending·0 cites
- 0282US7335646B2Compositions and methods for regulated protein expression in gutENGENE INC·Filed 2001·Granted Feb 26, 2008·14 cites·44 claims
- 0379US2023414769A1Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivoENGENE INC·Filed 2023·Application pending·0 cites
- 0478US12076418B2Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivoENGENE INC·Filed 2021·Granted Sep 3, 2024·0 cites·25 claims
- 0577US9623112B2Dually derivatized chitosan nanoparticles and methods of making and using the sameENGENE INC·Filed 2013·Granted Apr 18, 2017·2 cites·26 claims
- 0676US11167045B2Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivoENGENE INC·Filed 2019·Granted Nov 9, 2021·0 cites·21 claims
- 0775US11623011B2Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivoENGENE INC·Filed 2019·Granted Apr 11, 2023·0 cites·30 claims
- 0874US10456481B2Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivoENGENE INC·Filed 2018·Granted Oct 29, 2019·0 cites·10 claims
- 0969US9850323B2High concentration chitosan-nucleic acid polyplex compositionsENGENE INC·Filed 2014·Granted Dec 26, 2017·2 cites·20 claims
- 1066US10046066B2Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivoENGENE INC·Filed 2014·Granted Aug 14, 2018·0 cites·33 claims
- 1163US11603398B2Intestinal expression of programmed death ligand 1ENGENE INC·Filed 2017·Granted Mar 14, 2023·1 cites·12 claims
- 1262US2023416337A1Intestinal expression of programmed death ligand 1ENGENE INC·Filed 2023·Application pending·0 cites
- 1361US10647785B2High concentration chitosan-nucleic acid polyplex compositionsENGENE INC·Filed 2017·Granted May 12, 2020·0 cites·24 claims
- 1461US10456478B2Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivoENGENE INC·Filed 2017·Granted Oct 29, 2019·0 cites·33 claims
- 1555US2008120734A1Compositions and methods for regulated protein expression in gutENGENE INC·Filed 2008·Application pending·0 cites
- 1653US2009041740A1Cancer treatment by metabolic modulationsENGENE INC·Filed 2008·Application pending·0 cites
- 1750US2022395584A1Reversible coating of chitosan-nucleic acid nanoparticles and methods of their useENGENE INC·Filed 2020·Application pending·0 cites
- 1850US2022370637A1Chitosan polyplex-based localized expression of il-12 alone or in combination with type-i ifn inducers for treatment of mucosal cancersENGENE INC·Filed 2020·Application pending·0 cites
- 1948US2024148902A1Combination gene therapy for treatment of metastatic cancerENGENE INC·Filed 2022·Application pending·0 cites
- 2033US2010261780A1Highly Acidic Chitosan-Nucleic Acid Polyplex CompositionsENGENE INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ENGENE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →